| GC32908-10mM(1mLinDMSO) |
|
2031161-35-8 |
|
0 |
C20H15F4N3O2 |
|
|
|
| GC32907-100mg |
|
1242137-16-1 |
N-desmethyl Enzalutamide (N-desmethyl MDV 3100)
|
0 |
C20H14F4N4O2S |
|
|
|
| GC32907-50mg |
|
1242137-16-1 |
N-desmethyl Enzalutamide (N-desmethyl MDV 3100)
|
0 |
C20H14F4N4O2S |
|
|
|
| GC32907-10mg |
|
1242137-16-1 |
N-desmethyl Enzalutamide (N-desmethyl MDV 3100)
|
0 |
C20H14F4N4O2S |
|
|
|
| GC32907-5mg |
|
1242137-16-1 |
N-desmethyl Enzalutamide (N-desmethyl MDV 3100)
|
0 |
C20H14F4N4O2S |
|
|
|
| GC32907-10mM(1mLinDMSO) |
|
1242137-16-1 |
N-desmethyl Enzalutamide (N-desmethyl MDV 3100)
|
0 |
C20H14F4N4O2S |
|
|
|
| GC32906-10mg |
|
18696-26-9 |
|
0 |
C16H24NO5 |
|
|
|
| GC32906-5mg |
|
18696-26-9 |
|
0 |
C16H24NO5 |
|
|
|
| GC32906-10mM(1mLinDMSO) |
|
18696-26-9 |
|
0 |
C16H24NO5 |
|
|
|
| GC32905-100mg |
|
13655-52-2 |
Alprenolol ((RS)-Alprenolol)
|
0 |
C15H23NO2 |
|
|
|
| GC32905-50mg |
|
13655-52-2 |
Alprenolol ((RS)-Alprenolol)
|
0 |
C15H23NO2 |
|
|
|
| GC32905-10mM(1mLinDMSO) |
|
13655-52-2 |
Alprenolol ((RS)-Alprenolol)
|
0 |
C15H23NO2 |
|
|
|
| GC32904-100mg |
|
1650550-25-6 |
Enasidenib mesylate (AG-221 mesylate)
|
0 |
C20H21F6N7O4S |
|
|
|
| GC32904-50mg |
|
1650550-25-6 |
Enasidenib mesylate (AG-221 mesylate)
|
0 |
C20H21F6N7O4S |
|
|
|
| GC32904-10mg |
|
1650550-25-6 |
Enasidenib mesylate (AG-221 mesylate)
|
0 |
C20H21F6N7O4S |
|
|
|
| GC32904-5mg |
|
1650550-25-6 |
Enasidenib mesylate (AG-221 mesylate)
|
0 |
C20H21F6N7O4S |
|
|
|
| GC32904-10mM(1mLinDMSO) |
|
1650550-25-6 |
Enasidenib mesylate (AG-221 mesylate)
|
0 |
C20H21F6N7O4S |
|
|
|
| GC32903-2g |
|
2225940-52-1 |
E3 Ligase Ligand-Linker Conjugates 22
|
0 |
C23H32N4O8 |
|
|
|
| GC32903-1g |
|
2225940-52-1 |
E3 Ligase Ligand-Linker Conjugates 22
|
0 |
C23H32N4O8 |
|
|
|
| GC32903-500mg |
|
2225940-52-1 |
E3 Ligase Ligand-Linker Conjugates 22
|
0 |
C23H32N4O8 |
|
|
|
